For psoriasis, review finds several biosimilars as safe and effective as biologicsJune 30, 2023PsoriasisPsoriatic ArthritisBusiness of Medicine
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?June 30, 2023Psoriatic ArthritisPsoriasis
Methotrexate does not impair sperm quality, small study findsJune 21, 2023Psoriatic ArthritisPsoriasis
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricingJune 16, 2023Business of MedicinePsoriatic ArthritisPediatricsPsoriasis
Cell activity in psoriasis may predict disease severity and provide clues to comorbiditiesJune 7, 2023PsoriasisPsoriatic Arthritis
FDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
FDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023PediatricsPsoriatic ArthritisRare DiseasesPsoriasis
Axial spondyloarthritis versus axial psoriatic arthritis: Different entities?May 9, 2023Psoriatic ArthritisPsoriasis
COVID-19 and psoriasis: Is there a link?May 4, 2023PsoriasisInfectious DiseasesCOVID-19 UpdatesPsoriatic Arthritis
Researchers seek to understand post-COVID autoimmune disease riskMay 1, 2023COVID-19 UpdatesLong COVIDPsoriasis
Meta-analysis examines cancer risk concern for JAK inhibitorsApril 26, 2023Psoriatic ArthritisPediatricsPsoriasis
NPF provides guidance for virtual psoriasis visitsApril 24, 2023PsoriasisMedical DermatologyBusiness of MedicinePsoriatic Arthritis
BergamotApril 17, 2023Aesthetic DermatologyPsoriasisPigmentation DisordersAcneNonmelanoma Skin Cancer
